During the third quarter, Cullen Frost Bankers Inc. increased its stake in Intuitive Surgical by 4.4%, acquiring an additional 3,450 shares to bring its total holdings to 82,056 shares, valued at approximately 36.7 million dollars per the latest SEC filing. This build-up complements similar moves by other institutions: Commerzbank Aktiengesellschaft FI upped its position by 6.8% to 11,802 shares, Whittier Trust Co. of Nevada increased its holdings by 8.8% to 49,093 shares, and CIBC Asset Management boosted its ownership by 1.3% to 159,566 shares. Overall, institutional investors and hedge funds now control more than 83% of Intuitive Surgical’s outstanding shares, signaling strong confidence in the company’s long-term prospects among professional asset managers.

Research firms have grown more optimistic on Intuitive Surgical’s growth trajectory, with Truist Financial, Royal Bank of Canada, BTIG Research, Leerink Partners and HSBC all raising their price targets and reiterating buy or outperform ratings in recent months. As a group, the analyst community rates the company as a Moderate Buy, with a majority of analysts forecasting double-digit revenue growth driven by increasing procedure volume and expanding service revenues. One firm has gone as far as issuing a Strong Buy recommendation, reflecting expectations that the company’s innovative robotics platforms will sustain market leadership and support margin expansion over the next fiscal year.

Senior executives have been net sellers of company stock over the latest quarter, with Senior Vice President Mark Brosius divesting 464 shares and Director Craig H. Barratt selling 750 shares, according to SEC disclosures. Combined insider sales totaled 55,714 shares valued at over 31.6 million dollars during the period, reducing insider ownership to less than 1% of total shares outstanding. While such transactions often raise questions about executive conviction, the relatively small size of their remaining holdings suggests that these sales may have been for personal liquidity rather than a lack of confidence in the business model.

In its most recent quarterly report, Intuitive Surgical posted earnings per share that exceeded consensus estimates by more than 10% and delivered year-over-year revenue growth of 18.8%, driven by higher procedure volumes for its da Vinci systems and a record number of service agreements. Management guided to mid-teens percentage procedure growth for the next fiscal year, a slight deceleration from the current pace but still robust given ongoing macroeconomic pressures in Europe and evolving healthcare reimbursement dynamics. The company reiterated its commitment to R&D investments in next-generation platforms and software, underscoring a multi-year roadmap for new procedural indications and further expansion into emerging markets.